Filing Details

Accession Number:
0001415889-21-002000
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-14 19:32:15
Reporting Period:
2021-04-12
Accepted Time:
2021-04-14 19:32:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1697362 Burkes Michael Brophy C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-12 36,666 $0.00 106,487 No 4 M Direct
Common Stock Disposition 2021-04-13 14,616 $104.21 91,871 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2021-04-12 36,666 $0.00 36,666 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Represents the full vesting and settlement of Restricted Stock Units ("RSUs").
  2. Each RSU represents a contingent right to receive one share of common stock of the issuer.
  3. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs pursuant to Rule 10b5-1.
  4. The RSUs vested upon the determination of the issuer's Compensation Committee to vest the award, subject to trading restrictions on the underlying shares.